Roflumilast: a review of its use in the treatment of COPD

International Journal of Chronic Obstructive Pulmonary Disease
Jadwiga A WedzichaKlaus F Rabe

Abstract

COPD is a progressive condition involving chronic inflammation and parenchymal destruction with resulting airflow limitation. COPD is associated with worsening airflow limitation over time and increased frequency of COPD exacerbations, leading to increased mortality and morbidity. The effects of COPD extend beyond the lungs, as multiple comorbidities may occur with COPD, including cardiovascular disease, diabetes mellitus, osteoporosis, depression, and pneumonia. COPD exacerbations are associated with a rapid worsening of baseline symptoms that requires prompt management and may necessitate hospitalization in the case of a severe episode. Patients with COPD exacerbations require urgent management of symptoms to prevent further worsening, and preventative steps may be taken to help reduce the number and frequency of future exacerbations. Roflumilast is a potent and selective inhibitor of the enzyme phosphodiesterase-4 that targets the systemic inflammation associated with COPD. Roflumilast has a variety of anti-inflammatory effects including decreasing inflammatory mediators and the expression of cell surface markers and inhibition of apoptosis. Several clinical trials evaluating roflumilast in the treatment of COPD have demonst...Continue Reading

Citations

Sep 11, 2016·Respiratory Research·Marc MiravitllesVladimir Koblizek
Dec 21, 2016·American Journal of Respiratory Cell and Molecular Biology·Brijeshkumar S PatelAlaina J Ammit
May 27, 2017·Expert Review of Respiratory Medicine·Amany F ElbehairyUNKNOWN Canadian Respiratory Research Network (CRRN)
Jan 21, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Wupeng LiaoWai-Shiu Fred Wong
Mar 24, 2018·Basic & Clinical Pharmacology & Toxicology·Øyvind Nicolay Ulland SalvesenDaniel Pilsgaard Henriksen
Jan 25, 2018·Jornal brasileiro de pneumologia : publicaça̋o oficial da Sociedade Brasileira de Pneumologia e Tisilogia·Frederico Leon Arrabal FernandesFernando Luiz Cavalcanti Lundgren
Sep 23, 2018·Respirology : Official Journal of the Asian Pacific Society of Respirology·Kate H Regan, Adam T Hill
Jul 7, 2017·The European Respiratory Journal·Klaus F RabeLeonardo M Fabbri
Dec 7, 2018·American Journal of Respiratory Cell and Molecular Biology·Michael B Fessler
Mar 7, 2020·The Korean Journal of Internal Medicine·Chin Kook Rhee, Deog Kyeom Kim
May 2, 2020·The Cochrane Database of Systematic Reviews·Sadia JanjuaPhillippa Poole
Apr 30, 2020·Journal of Internal Medicine·Giuseppe PascarellaFelice Eugenio Agrò
Nov 10, 2017·COPD·Peter M A CalverleyJadwiga A Wedzicha
Jun 10, 2017·American Journal of Clinical Dermatology·Tiago Torres, Luis Puig
Apr 20, 2018·American Journal of Respiratory and Critical Care Medicine·Alex J MackayJadwiga A Wedzicha
Jul 16, 2020·Therapeutic Advances in Respiratory Disease·Aishath Fazleen, Tom Wilkinson
Sep 19, 2020·International Journal of Chronic Obstructive Pulmonary Disease·Luis Pérez de LlanoBorja G Cosio
Apr 10, 2019·Current Pharmaceutical Biotechnology·Víctor M Muñoz-PérezMirandeli Bautista-Ávila
Jul 30, 2020·Respirology : Official Journal of the Asian Pacific Society of Respirology·Matthias H UrbanOtto C Burghuber
Apr 30, 2017·Current Heart Failure Reports·Valentina SalaEmilio Hirsch
Dec 20, 2019·Expert Review of Respiratory Medicine·Meghan Althoff, Fernando Holguin
Dec 7, 2016·American Journal of Respiratory and Critical Care Medicine·Nicholas J Gross, Peter J Barnes
Jan 5, 2021·The Journal of Clinical Investigation·Jaebeom ChoHo-Young Lee
Aug 1, 2020·Neuroscience Letters·Lal Jabaris S SuginK Narayan Sunil
Dec 2, 2020·Pulmonary Pharmacology & Therapeutics·Sugin Lal Jabaris S, Ranju V
Oct 30, 2020·Respiratory Medicine Case Reports·Veronica Ann VarneyZiyad Abubacker
Apr 4, 2021·Journal of Clinical Medicine·Rachana MandruRobert M Burkes
Apr 21, 2021·Cytokine·Ruby E DawsonMohamed I Saad

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy

Clinical Trials Mentioned

NCT01313494
NCT01329029
NCT01285167
NCT00361959
NCT01509677

Related Concepts

Related Feeds

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Related Papers

The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists
Maisha L Kelly Freeman
Therapeutics and Clinical Risk Management
Melissa Lipari, Pramodini B Kale-Pradhan
Primary Care Respiratory Journal : Journal of the General Practice Airways Group
David PriceRupert Jones
Archivos de bronconeumología
José Luis Izquierdo Alonso
© 2022 Meta ULC. All rights reserved